|
FAM98B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13349999999002E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.829800E-04 |
| Normal-vs-Stage2 |
4.101900E-03 |
| Normal-vs-Stage3 |
2.341699999997E-05 |
| Normal-vs-Stage4 |
2.22510000003062E-06 |
| Stage1-vs-Stage2 |
8.053000E-01 |
| Stage1-vs-Stage3 |
2.698200E-01 |
| Stage1-vs-Stage4 |
4.626100E-02 |
| Stage2-vs-Stage3 |
6.137800E-01 |
| Stage2-vs-Stage4 |
2.782800E-01 |
| Stage3-vs-Stage4 |
4.240400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.68049999999376E-05 |
| Normal-vs-AfricanAmerican |
7.605500E-02 |
| Normal-vs-Asian |
9.751900E-04 |
| Caucasian-vs-AfricanAmerican |
3.443800E-01 |
| Caucasian-vs-Asian |
7.741200E-01 |
| AfricanAmerican-vs-Asian |
3.079000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.15230000009259E-07 |
| Normal-vs-Female |
1.757830E-04 |
| Male-vs-Female |
1.021650E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.036000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.04819999999328E-05 |
| Normal-vs-Age(61-80Yrs) |
2.29219999999808E-05 |
| Normal-vs-Age(81-100Yrs) |
1.106030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.208800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.188200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.970800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.560600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.439800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.261200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.522000E-02 |
| Classical-VS-Follicular |
1.634340E-04 |
| Classical-VS-Other |
8.140100E-02 |
| Classical-VS-Normal |
2.036500E-03 |
| Tall-VS-Follicular |
3.034000E-01 |
| Tall-VS-Other |
2.825400E-01 |
| Tall-VS-Normal |
4.241200E-04 |
| Follicular-VS-Other |
6.648600E-01 |
| Follicular-VS-Normal |
4.03229999945687E-07 |
| Other-VS-Normal |
5.458500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.95963999999327E-05 |
| Normal-vs-N1 |
3.81710000000313E-05 |
| N0-vs-N1 |
4.779200E-01 |
|
|
